Home>>Signaling Pathways>> Neuroscience>> Histamine Receptor>>Cyproheptadine (hydrochloride hydrate)

Cyproheptadine (hydrochloride hydrate) Sale

(Synonyms: 盐酸赛庚啶半水合物) 目录号 : GC43353

An antihistamine with antiserotonergic and anticholinergic activities

Cyproheptadine (hydrochloride hydrate) Chemical Structure

Cas No.:41354-29-4

规格 价格 库存 购买数量
100mg
¥223.00
现货
250mg
¥503.00
现货
500mg
¥196.00
现货
1g
¥270.00
现货

电话:400-920-5774 Email: sales@glpbio.cn

Customer Reviews

Based on customer reviews.

Sample solution is provided at 25 µL, 10mM.

产品文档

Quality Control & SDS

View current batch:

产品描述

Cyproheptadine is a first-generation antihistamine that potently antagonizes the histamine H1 receptor (pKi = 9.42). It also antagonizes serotonin and muscarinic receptors at nanomolar concentrations. Cyproheptadine also inhibits the lysine methyltransferase SET7/9 (IC50 = 1 µM), suppressing the expression of estrogen receptor α in human breast cancer MCF-7 cells.

Chemical Properties

Cas No. 41354-29-4 SDF
别名 盐酸赛庚啶半水合物
Canonical SMILES CN(CC/1)CCC1=C2C(C=CC=C3)=C3C=CC4=C\2C=CC=C4.CN(CC/5)CCC5=C6C(C=CC=C7)=C7C=CC8=C\6C=CC=C8.Cl.O.O.O.Cl
分子式 C21H21N•HCl [1.5H2O] 分子量 350.9
溶解度 DMF: 30 mg/mL,DMSO: 30 mg/mL,Ethanol: 30 mg/mL,Ethanol:PBS(pH 7.2) (1:1): 0.5 mg/mL 储存条件 Store at -20°C
General tips 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。
为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。
Shipping Condition 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。

溶解性数据

制备储备液
1 mg 5 mg 10 mg
1 mM 2.8498 mL 14.2491 mL 28.4981 mL
5 mM 0.57 mL 2.8498 mL 5.6996 mL
10 mM 0.285 mL 1.4249 mL 2.8498 mL
  • 摩尔浓度计算器

  • 稀释计算器

  • 分子量计算器

质量
=
浓度
x
体积
x
分子量
 
 
 
*在配置溶液时,请务必参考产品标签上、MSDS / COA(可在Glpbio的产品页面获得)批次特异的分子量使用本工具。

计算

动物体内配方计算器 (澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 ul 动物数量
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方)
% DMSO % % Tween 80 % saline
计算重置

Research Update

Serotonin Syndrome Triggered by Overuse of Caffeine and Complicated With Neuroleptic Malignant Syndrome: A Case Report

Cureus 2022 Feb 21;14(2):e22468.PMID:35345760DOI:PMC8942071

Serotonin syndrome is a rare complication occurring in patients with psychiatric disorders that are treated with selective serotonin reuptake inhibitors (SSRIs). There are various triggers for serotonin syndrome, including non-SSRI antidepressants. In rare cases, serotonin syndrome may be triggered by nonmedicinal foods, such as coffee. The patient described in this case report was a 65-year-old woman with a past medical history of major depression and a diagnosis of Parkinson's disease who presented to our medical center with chief complaints of nausea, vomiting, and drowsiness. She had previously been prescribed paroxetine hydrochloride hydrate for depression, and she was prescribed levodopa and carbidopa for Parkinson's disease. She also drank 20 cups of coffee in a short period of time two days prior to admission due to excessive sleepiness. She was diagnosed with serotonin syndrome based on her clinical symptomology, which included diaphoresis, mydriasis, fine tremor, myoclonus, hypertension, and tachycardia. She was treated with diazepam and Cyproheptadine hydrochloride hydrate. Later, she experienced muscle pain with increased creatinine kinase levels after she failed to take levodopa and carbidopa. These findings were suggestive of neuroleptic malignant syndrome. The patient was treated with supportive care. Excessive coffee intake triggers serotonin syndrome by promoting 5-hydroxytryptamine (serotonin) secretion. Patients with psychiatric diseases that necessitate treatment with SSRIs should be educated regarding caffeine consumption. Moreover, patients presenting with agitation and drowsiness should be evaluated for serotonin syndrome within the differential diagnosis. Patients with depression and Parkinson's syndrome should be evaluated for associated comorbidities, particularly serotonin syndrome and neuroleptic malignant syndrome.